Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
PTI Proteostasis Therapeutics Inc
CALB California BanCorp
$NOPM2 Refinitiv Norway Metal & Mining Inde
EBAY eBay Inc
PTON Peloton Interactive Inc
GO Grocery Outlet Holding Corp
NUE Nucor Corp
SJM J M Smucker Co
KR Kroger Co
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Postmarket

Last Trade
Delayed
$144.00
0.13 (0.09%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$143.87
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
144.77
Day's Low
143.61
Volume
(Heavy Day)
Volume:
11,035,965

10-day average volume:
7,026,433
11,035,965

Varian Congratulates Historic Trade Package Agreement with Brazil

8:15 am ET October 20, 2020 (PR Newswire) Print

Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil on achieving the first steps of a trade agreement focused on good regulatory practices, trade facilitation, and anti-corruption. Varian's Chief Executive Officer, Dow Wilson, serves as the private sector co-chair of the U.S.-Brazil CEO Forum. The U.S.-Brazil CEO Forum is co-chaired on the government side by U.S. Commerce Secretary Wilbur Ross, U.S. Director of the National Economic Council Larry Kudlow, Brazilian Minister of Economy Paulo Guedes, and Brazilian Chief of Staff to the President, Walter Souza Braga Netto. Mr. Marco Stefanini, CEO and founder of Stefanini IT Solutions, is the Brazilian private sector co-chair.

"This is a historic moment in the bilateral relationship, and, as the private sector co-Chair of the U.S.-Brazil CEO Forum, we are pleased to have had the opportunity to offer recommendations and meaningful commercial priorities throughout the negotiation process," said Dow Wilson. "Agreement on Good Regulatory Practices and Trade Facilitation are essential for our mutual economic prosperity, and we extend our sincere appreciation and congratulations to both governments in reaching this milestone. We look forward to contributing to the implementation of this agreement and further progress removing barriers to trade between our two great markets."

About Varian

At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press ContactsAimee CorsoHealth+Commerce+1 (310) 780-2661aimee@healthandcommerce.com

Investor Relations ContactAnshul MaheshwariVice President, Investor Relations+1 (650) 424-5631investors@varian.com

https://c212.net/c/img/favicon.png?sn=SF63696&sd=2020-10-20

View original content:http://www.prnewswire.com/news-releases/varian-congratulates-historic-trade-package-agreement-with-brazil-301155602.html

SOURCE Varian

https://rt.prnewswire.com/rt.gif?NewsItemId=SF63696&Transmission_Id=202010200815PR_NEWS_USPR_____SF63696&DateId=20201020

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.